Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

A 'recovery care package' post-treatment in Africa

Cancer control in low and middle income countries: New solutions to evolving challenges

Published: 28 Feb 2020

Views: 777

Rating:

Save

Prof Theresa Wiseman - Royal Marsden Hospital, London, UK

Prof Theresa Wiseman speaks to ecancer at CCLMIC 2019 about two of the the global challenge research fund projects.

She outlines the two projects involved, and explains how her 'recovery care package' was integrated into these at the end of the patients' treatment.

Hopefully these projects could be expanded and rolled out on a national level.

Related Videos

Innovating cancer care access for low and middle-income countries

Lacy Hubbard - Founding President and CEO, Elekta Foundation

Innovating cancer care access for low and middle-income countries ( Lacy Hubbard - Founding President and CEO, Elekta Foundation )

Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations

Dr Dario Trapani - European Institute of Oncology, IRCCS, Milan, Italy

Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations ( Dr Dario Trapani - European Institute of Oncology, IRCCS, Milan, Italy )

Prostate cancer

Dr Alison Tree - Institute of Cancer Research, London, UK

Prostate cancer ( Dr Alison Tree - Institute of Cancer Research, London, UK )

Rectal cancer

Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada

Rectal cancer ( Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada )

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres

Aminu Umar-Sadiq - MD & CEO, Nigeria Sovereign Investment Authority (NSIA)

NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres ( Aminu Umar-Sadiq - MD & CEO, Nigeria Sovereign Investment Authority (NSIA) )

Time toxicity: the burden on cancer patients

Dr Arjun Gupta - University of Minnesota, Minneapolis, USA

Time toxicity: the burden on cancer patients ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )

More from ecancer